Rifapentine
Antibiotic used to treat tuberculosis
Rifapentine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Rifapentine is an antibiotic used in the treatment of tuberculosis (TB). It is a member of the rifamycin class of antibiotics, which are known for their ability to inhibit bacterial RNA polymerase, thereby preventing the synthesis of bacterial RNA and protein.
Medical uses[edit | edit source]
Rifapentine is primarily used in the treatment of active tuberculosis and latent tuberculosis infection. It is often used in combination with other antitubercular drugs such as isoniazid and pyrazinamide to enhance efficacy and prevent the development of drug resistance.
Active tuberculosis[edit | edit source]
In the treatment of active tuberculosis, rifapentine is used as part of a combination therapy. It is typically administered once or twice weekly, depending on the phase of treatment. The use of rifapentine in combination with other drugs helps to shorten the duration of therapy and improve patient adherence.
Latent tuberculosis infection[edit | edit source]
For latent tuberculosis infection, rifapentine is used in combination with isoniazid in a regimen known as the "3HP" regimen, which involves once-weekly dosing for 12 weeks. This regimen has been shown to be as effective as longer regimens and is associated with better patient compliance.
Mechanism of action[edit | edit source]
Rifapentine works by inhibiting the bacterial DNA-dependent RNA polymerase, an enzyme essential for the transcription of DNA into RNA. By blocking this enzyme, rifapentine effectively halts the production of bacterial proteins, leading to the death of the bacteria.
Side effects[edit | edit source]
Common side effects of rifapentine include nausea, vomiting, and diarrhea. It can also cause hepatotoxicity, which is a concern with all rifamycin antibiotics. Patients taking rifapentine may experience orange discoloration of bodily fluids, such as urine and tears, which is a harmless but notable side effect.
Drug interactions[edit | edit source]
Rifapentine is a potent inducer of cytochrome P450 enzymes, which can lead to significant drug interactions. It can decrease the effectiveness of other medications metabolized by these enzymes, such as oral contraceptives, anticoagulants, and certain antiretroviral drugs.
Pharmacokinetics[edit | edit source]
Rifapentine is well absorbed from the gastrointestinal tract and has a long half-life, which allows for less frequent dosing compared to other rifamycins. It is metabolized in the liver and excreted primarily in the bile.
History[edit | edit source]
Rifapentine was developed as a derivative of rifampicin with a longer half-life, allowing for less frequent dosing. It was approved for medical use in the United States in 1998.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD, Spt